110 related articles for article (PubMed ID: 23100233)
1. FISH analysis using PPAR γ-specific probes for detection of PAX8-PPAR γ translocation in follicular thyroid neoplasms.
Sharifah NA; Zakaria Z; Chia WK
Methods Mol Biol; 2013; 952():187-96. PubMed ID: 23100233
[TBL] [Abstract][Full Text] [Related]
2. A subset of the follicular variant of papillary thyroid carcinoma harbors the PAX8-PPARgamma translocation.
Castro P; Roque L; Magalhães J; Sobrinho-Simões M
Int J Surg Pathol; 2005 Jul; 13(3):235-8. PubMed ID: 16086077
[TBL] [Abstract][Full Text] [Related]
3. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic implications of the PAX8-PPARγ translocation in thyroid carcinomas-a TMA-based study of 226 cases.
Boos LA; Dettmer M; Schmitt A; Rudolph T; Steinert H; Moch H; Sobrinho-Simões M; Komminoth P; Perren A
Histopathology; 2013 Aug; 63(2):234-41. PubMed ID: 23738683
[TBL] [Abstract][Full Text] [Related]
5. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
[TBL] [Abstract][Full Text] [Related]
6. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
[TBL] [Abstract][Full Text] [Related]
7. Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR.
Klemke M; Drieschner N; Belge G; Burchardt K; Junker K; Bullerdiek J
Genes Chromosomes Cancer; 2012 Apr; 51(4):402-8. PubMed ID: 22179975
[TBL] [Abstract][Full Text] [Related]
8. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the PAX8/PPARG translocation in follicular thyroid cancer with a 4-color reverse-transcription PCR assay and automated high-resolution fragment analysis.
Algeciras-Schimnich A; Milosevic D; McIver B; Flynn H; Reddi HV; Eberhardt NL; Grebe SK
Clin Chem; 2010 Mar; 56(3):391-8. PubMed ID: 20056739
[TBL] [Abstract][Full Text] [Related]
10. PAX8-PPARgamma oncogene in follicular thyroid tumors: RT-PCR and immunohistochemical analyses.
Pauzar B; Karner I; Glavas-Obrovac L; Stefanić M; Dmitrović B
Coll Antropol; 2012 Nov; 36 Suppl 2():79-82. PubMed ID: 23397760
[TBL] [Abstract][Full Text] [Related]
11. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
[TBL] [Abstract][Full Text] [Related]
12. Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.
Lui WO; Foukakis T; Lidén J; Thoppe SR; Dwight T; Höög A; Zedenius J; Wallin G; Reimers M; Larsson C
Oncogene; 2005 Feb; 24(8):1467-76. PubMed ID: 15608688
[TBL] [Abstract][Full Text] [Related]
13. Fluorescence in situ hybridization analysis of formalin fixed paraffin embedded tissues, including tissue microarrays.
Summersgill BM; Shipley JM
Methods Mol Biol; 2010; 659():51-70. PubMed ID: 20809303
[TBL] [Abstract][Full Text] [Related]
14. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
[TBL] [Abstract][Full Text] [Related]
15. PAX8-peroxisome proliferator-activated receptor gamma (PPARgamma) disrupts normal PAX8 or PPARgamma transcriptional function and stimulates follicular thyroid cell growth.
Au AY; McBride C; Wilhelm KG; Koenig RJ; Speller B; Cheung L; Messina M; Wentworth J; Tasevski V; Learoyd D; Robinson BG; Clifton-Bligh RJ
Endocrinology; 2006 Jan; 147(1):367-76. PubMed ID: 16179407
[TBL] [Abstract][Full Text] [Related]
16. Improved technique for analysis of formalin-fixed, paraffin-embedded tumors by fluorescence in situ hybridization.
Hyytinen E; Visakorpi T; Kallioniemi A; Kallioniemi OP; Isola JJ
Cytometry; 1994 Jun; 16(2):93-9. PubMed ID: 7924686
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of PAX8-PPARγ rearrangement in follicular thyroid carcinomas in Japanese patients.
Mochizuki K; Kondo T; Oishi N; Tahara I; Inoue T; Kasai K; Nakazawa T; Okamoto T; Shibata N; Katoh R
Pathol Int; 2015 May; 65(5):250-3. PubMed ID: 25708358
[TBL] [Abstract][Full Text] [Related]
18. The PAX8/PPAR gamma fusion oncogene as a potential therapeutic target in follicular thyroid carcinoma.
McIver B; Grebe SK; Eberhardt NL
Curr Drug Targets Immune Endocr Metabol Disord; 2004 Sep; 4(3):221-34. PubMed ID: 15379724
[TBL] [Abstract][Full Text] [Related]
19. The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.
Foukakis T; Au AY; Wallin G; Geli J; Forsberg L; Clifton-Bligh R; Robinson BG; Lui WO; Zedenius J; Larsson C
J Clin Endocrinol Metab; 2006 Mar; 91(3):1143-9. PubMed ID: 16352687
[TBL] [Abstract][Full Text] [Related]
20. Aneuploidy and RAS mutations are mutually exclusive events in the development of well-differentiated thyroid follicular tumours.
Banito A; Pinto AE; Espadinha C; Marques AR; Leite V
Clin Endocrinol (Oxf); 2007 Nov; 67(5):706-11. PubMed ID: 17651453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]